{"cdcTestId":"2013-0531","testcaseName":"1 single antigen dose at 12M: 1 Measles","vaccineGroup":"MMR","evaluationTestType":"Single Antigen Administration","forecastTestType":"Recommended based on minimum interval from previous dose (catch-up)","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ATTENUVAX","cvx":"05","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"1","earliestDate":"2022-11-19T00:00:00","recommendedDate":"2022-11-19T00:00:00","pastDueDate":"2023-03-18T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ATTENUVAX","cvx":"05","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2019-08-22T07:26:15.516","generalDescription":"This test case describes when a child is administered single antigen dose of Measles, at the minimum age of 12 months that the a second dose is recommended.","changedInVersion":"1.4","reasonForChange":"Renamed to better reflect test case. V1.4: Updated Earliest and Recommended date to adjust dates out 3 days.  Previous recommendation was 4 weeks from single dose administration, but this would result in the dose being forecasted too early for the second Measles at 13 months."}